Studies on concentration-time profiles of nimodipine enantiomers following intravenous and oral administration of nimodipine in patients with subarachnoid hemorrhage

Chirality

Volumn 12, Issue 9, 2000, Pages 660-664

  Wanner Olsen, Henrik ^a   Gaarskær, Frank B ^a   Mikkelsen, Erich O ^b   Jakobsen, Preben ^b   Voldby, Bo ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Concentration time; Enantiomers; Neurosurgery; Nimodipine; Steady state; Stereoselective high performance liquid chromatography

Indexed keywords

NIMODIPINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRUG UPTAKE; ENANTIOMER; FEMALE; GASTROINTESTINAL ABSORPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; STEADY STATE; STEREOCHEMISTRY; SUBARACHNOID HEMORRHAGE; TIME;

ADMINISTRATION, ORAL; ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KINETICS; MALE; MIDDLE AGED; NIMODIPINE; STEREOISOMERISM; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS;

EID: 0034424762     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-636X(2000)12:9<660::AID-CHIR3>3.0.CO;2-1     Document Type: Article

References (13)

1. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments
2. Cerebral arterial spasm - A controlled trial of nimodipine in patients with subarachnoid hemorrhage
3. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial
4. Traumatic subarachnoid hemorrhage and its treatment with nimodipine
5. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A metaanalysis
6. Nimodipine treatment in poor-grade aneurysm patients
7. Drug chirality and its clinical significance
8. The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle
9. Stereoselective inhibition of calmodulin-dependent cAMP phosphodiesterase from bovine heart by (+)-(R)- and (-)-(S)-nimodipine
10. Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope technique
11. Nimodipine treatment of subarachnoid hemorrhage
12. Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage
13. Ca2+ (-)-(S)dependent and Ca2+(-)-(S)independent vasorelaxation induced by cardiotonic phosphodiesterase inhibitors